Neuronetics, Inc. (STIM)

USD 3.8

(0.8%)

Net Debt Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual net debt in 2023 was 2.79 Million USD , up 109.14% from previous year.
  • Neuronetics, Inc.'s latest quarterly net debt in 2024 Q2 was 19.98 Million USD , up 35.51% from previous quarter.
  • Neuronetics, Inc. reported annual net debt of -30.59 Million USD in 2022, up 43.96% from previous year.
  • Neuronetics, Inc. reported annual net debt of -54.59 Million USD in 2021, down -414.0% from previous year.
  • Neuronetics, Inc. reported quarterly net debt of 19.98 Million USD for 2024 Q2, up 35.51% from previous quarter.
  • Neuronetics, Inc. reported quarterly net debt of 4.35 Million USD for 2023 Q3, up 176.38% from previous quarter.

Annual Net Debt Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Net Debt of Neuronetics, Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 2.79 Million USD 109.14%
2022 -30.59 Million USD 43.96%
2021 -54.59 Million USD -414.0%
2020 -10.62 Million USD 74.33%
2019 -41.38 Million USD 44.22%
2018 -74.18 Million USD -18238.88%
2017 409 Thousand USD -86.8%
2016 3.09 Million USD 0.0%

Peer Net Debt Comparison of Neuronetics, Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD 107.09%
Applied DNA Sciences, Inc. -5.91 Million USD 147.294%
Aspira Women's Health Inc. -331 Thousand USD 945.015%
Biodesix, Inc. 34.3 Million USD 91.847%
BioNexus Gene Lab Corp. -5.79 Million USD 148.258%
bioAffinity Technologies, Inc. -1.24 Million USD 325.033%
bioAffinity Technologies, Inc. -1.24 Million USD 325.033%
Bionano Genomics, Inc. 34.88 Million USD 91.982%
CareDx, Inc -47.97 Million USD 105.83%
Check-Cap Ltd. -24.75 Million USD 111.298%
Castle Biosciences, Inc. -83.53 Million USD 103.348%
DarioHealth Corp. -7.54 Million USD 137.056%
Exact Sciences Corporation 1.94 Billion USD 99.857%
Fulgent Genetics, Inc. -82.56 Million USD 103.388%
Guardant Health, Inc. 220.22 Million USD 98.73%
ICON Public Limited Company 3.56 Billion USD 99.921%
IDEXX Laboratories, Inc. 493.94 Million USD 99.434%
Illumina, Inc. 1.21 Billion USD 99.77%
Intelligent Bio Solutions Inc. -5.43 Million USD 151.485%
iSpecimen Inc. -2.14 Million USD 230.249%
Standard BioTools Inc. 46.5 Million USD 93.986%
MDxHealth SA 18.88 Million USD 85.189%
23andMe Holding Co. -141.37 Million USD 101.978%
Medpace Holdings, Inc. -103.32 Million USD 102.707%
Myriad Genetics, Inc. 88.1 Million USD 96.825%
Mainz Biomed B.V. 349.85 Thousand USD -699.474%
ENDRA Life Sciences Inc. -2.43 Million USD 214.654%
NeoGenomics, Inc. 269.19 Million USD 98.961%
Neogen Corporation 735.62 Million USD 99.62%
Inotiv, Inc. 382.14 Million USD 99.268%
Natera, Inc. -200.1 Million USD 101.398%
OpGen, Inc. 11.89 Million USD 76.48%
OPKO Health, Inc. 230.68 Million USD 98.788%
Psychemedics Corporation 334 Thousand USD -737.425%
Prenetics Global Limited -43.33 Million USD 106.454%
Prenetics Global Limited -43.33 Million USD 106.454%
Precipio, Inc. -386 Thousand USD 824.611%
Personalis, Inc. -8.02 Million USD 134.867%
RadNet, Inc. 1.14 Billion USD 99.756%
Sera Prognostics, Inc. -2.02 Million USD 238.328%
Sotera Health Company 2.02 Billion USD 99.862%
Star Equity Holdings, Inc. -15.33 Million USD 118.237%
Star Equity Holdings, Inc. -15.33 Million USD 118.237%
Trinity Biotech plc 63.73 Million USD 95.612%
T2 Biosystems, Inc. 33.8 Million USD 91.727%
Twist Bioscience Corporation -192.4 Million USD 101.454%
Exagen Inc. -12.77 Million USD 121.899%